Study of Ingavirin® Antiviral Activity against Mexican Pandemic Influenza Virus A/H1N1/2009 in vitro and in vivo

Study of Ingavirin® Antiviral Activity against Mexican Pandemic Influenza Virus A/H1N1/2009 in vitro and in vivo

High in vitro and in vivo efficacy of Ingavirin® against the Mexican pandemic influenza virus A/H1N1/2009, strains A/California/ 04/2009 (H1N1) and A/California/07/2009 (H1N1) vs. the reference drug Arbidol® was studied and verified when used therapeutically and prophylactically.

Saved in:
Bibliographic Details
Main Authors: S. YA. Loginova, S. V. Borisevich, V. N. Shchukina, M. V. Lykov, G. V. Borisevich, V. P. Bondarev, V. E. Nebolsin, O. A. Sutochnikova, A. G. Chychalin
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2020-05-01
Series:Антибиотики и Химиотерапия
Subjects:
influenza virus a (h1n1)
infavirin®
antiviral activity
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/340
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:High in vitro and in vivo efficacy of Ingavirin® against the Mexican pandemic influenza virus A/H1N1/2009, strains A/California/ 04/2009 (H1N1) and A/California/07/2009 (H1N1) vs. the reference drug Arbidol® was studied and verified when used therapeutically and prophylactically.
ISSN:0235-2990

Similar Items